Google
Trusted Resources: News & Events
Latest announcements and gatherings
Small chips, big impact: MSU researcher studies cardiovascular, sickle cell disease
A Mississippi State University researcher is developing new miniature models to better understand the factors that lead to heart disease and sickle cell anemia.
Renita Horton, assistant professor of agricultural and biological engineering, is using clear polymer “chips” to create cellularized microtissue models, which she then uses to study the mechanisms that lead to cardiovascular related diseases. She hopes this work can aid in improving patient outcomes by identifying novel targets that can be exploited to mitigate some of the organ damage caused by sickle cell disease.
+myBinderRelated Content
-
Potential Association between Sickle Trait and MRI-Defined Cerebrovascular Outcomes in Two Multi-Ethnic Elderly Popu...Sickle cell disease is a risk factor for...
-
Patients With Sickle Cell Disease may Have Lower Risk for C. DifficileFindings from a retrospective cohort stu...
-
Nitric Oxide, Phosphodiesterase Inhibitors and Soluble Guanylate Cyclase Stimulators as Candidate Treatments for Sic...Despite being described in the medical l...
-
Orphan Drug Designation Granted for CSL Behring’s Investigational Plasma-Derived Hemopexin Therapy for Sickle ...Global biotherapeutics leader CSL Behrin...
-
Gut Microbiome Translates Stress Into Sickle Cell CrisesA new study shows how chronic psychologi...
-
Quest Diagnostics Launches Genetic Test to Assess Risk for Sickle Cell Anemia, Other Inherited DisordersCouples who wish to know the risk of pas...
-
Phase 1 trial to test under-the-skin injection of sevuparin in sickle cell patientsModus Therapeutics is going to launch ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.